北陆药业
(300016)
| 流通市值：46.41亿 | | | 总市值：46.49亿 |
| 流通股本：4.93亿 | | | 总股本：4.93亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 544,718,169.73 | 257,459,047.29 | 281,772,393.85 | 473,326,698.53 |
| 应收票据及应收账款 | 170,025,849.41 | 176,069,638.49 | 156,555,006.69 | 184,440,387.05 |
| 其中：应收票据 | 9,385,423.78 | 5,792,056.47 | 2,174,799.46 | 1,355,958.3 |
| 应收账款 | 160,640,425.63 | 170,277,582.02 | 154,380,207.23 | 183,084,428.75 |
| 预付款项 | 28,882,047.98 | 9,081,666.18 | 25,077,962.62 | 14,441,346.35 |
| 其他应收款合计 | 565,725.51 | 2,625,695.74 | 1,891,584.36 | 785,900.67 |
| 存货 | 354,585,925.9 | 362,094,049.65 | 323,934,232.06 | 309,484,858.65 |
| 一年内到期的非流动资产 | 291,007.69 | 291,007.69 | 117,729.47 | 116,501.91 |
| 其他流动资产 | 18,658,624.12 | 12,784,805.88 | 7,460,734.67 | 10,511,576.5 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,407,376,183.43 | 1,171,178,271.53 | 1,213,615,397.43 | 1,270,107,269.66 |
| 非流动资产: | | | | |
| 长期应收款 | 1,262,655.07 | 1,425,859.27 | 1,680,043.78 | 1,662,526.09 |
| 长期股权投资 | 195,996,208.94 | 196,640,803.29 | 197,251,845.36 | 197,731,740.57 |
| 其他权益工具投资 | 100,000 | 100,000 | 100,000 | 100,000 |
| 其他非流动金融资产 | 339,312,788.94 | 340,018,443.23 | 343,995,912.51 | 348,416,307.91 |
| 固定资产 | 872,777,505.68 | 892,074,537.92 | 905,335,894.8 | 818,665,369.07 |
| 在建工程 | 92,088,109.95 | 70,257,852.16 | 56,200,335.18 | 139,715,218.57 |
| 生产性生物资产 | 5,876,496.02 | 6,088,772.36 | 5,884,554.22 | 6,132,209.95 |
| 使用权资产 | 1,040,608.44 | 7,612,134.14 | 8,395,770.62 | 9,688,662.78 |
| 无形资产 | 157,614,059.3 | 160,824,686.4 | 164,659,320.42 | 169,457,104.89 |
| 商誉 | 46,924,655.17 | 46,924,655.17 | 46,924,655.17 | 46,924,655.17 |
| 长期待摊费用 | 22,484,304.97 | 24,944,258.8 | 20,859,820.15 | 16,279,237.04 |
| 递延所得税资产 | 37,071,887.42 | 41,331,690.55 | 32,580,976.92 | 33,154,506.55 |
| 其他非流动资产 | 26,953,271.25 | 18,109,264.84 | 13,189,982.62 | 9,717,446.36 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,799,502,551.15 | 1,806,352,958.13 | 1,797,059,111.75 | 1,797,644,984.95 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,206,878,734.58 | 2,977,531,229.66 | 3,010,674,509.18 | 3,067,752,254.61 |
| 流动负债: | | | | |
| 短期借款 | 215,119,142.22 | 140,019,395.38 | 190,304,423.34 | 243,381,504.94 |
| 交易性金融负债 | 11,531,047.26 | 11,130,961.55 | 11,576,158.6 | 11,332,113.71 |
| 应付票据及应付账款 | 147,858,962.61 | 171,317,020.02 | 156,611,746.11 | 162,206,046.86 |
| 其中：应付票据 | 66,844,033.35 | 58,918,683.58 | 56,353,383.43 | 68,078,367.27 |
| 应付账款 | 81,014,929.26 | 112,398,336.44 | 100,258,362.68 | 94,127,679.59 |
| 合同负债 | 6,056,172.5 | 8,757,893.35 | 5,279,784.17 | 3,175,148.38 |
| 应付职工薪酬 | 14,328,056.71 | 25,932,910.4 | 15,899,179.95 | 15,629,854.04 |
| 应交税费 | 10,034,976.87 | 4,726,522.63 | 4,041,564.98 | 11,384,574.23 |
| 其他应付款合计 | 34,004,729.42 | 25,912,555.61 | 23,801,681.82 | 24,718,971.96 |
| 一年内到期的非流动负债 | 112,517,653.15 | 63,647,006.3 | 39,302,525.8 | 34,069,036.56 |
| 其他流动负债 | 10,417,976.91 | 3,782,167.57 | 437,143.76 | 127,636.28 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 561,868,717.65 | 455,226,432.81 | 447,254,208.53 | 506,024,886.96 |
| 非流动负债: | | | | |
| 长期借款 | 197,000,000 | 101,100,000 | 141,888,000 | 151,100,000 |
| 应付债券 | 507,879,346.91 | 499,135,640.01 | 489,873,226.89 | 480,496,426.37 |
| 租赁负债 | 252,476.59 | 4,804,289.69 | 5,625,996.85 | 6,376,866.97 |
| 递延收益 | 27,255,577.51 | 16,841,951.14 | 11,788,668.23 | 12,024,758.94 |
| 递延所得税负债 | 68,320,164.7 | 70,934,681.55 | 66,239,313.63 | 68,934,930.9 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 800,707,565.71 | 692,816,562.39 | 715,415,205.6 | 718,932,983.18 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,362,576,283.36 | 1,148,042,995.2 | 1,162,669,414.13 | 1,224,957,870.14 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 491,946,978 | 491,946,696 | 491,935,176 | 491,935,176 |
| 其他权益工具 | 112,570,410.48 | 112,570,941.09 | 112,593,376.73 | 112,593,376.73 |
| 资本公积 | 135,340,111.27 | 135,337,857.14 | 135,224,094.88 | 135,224,094.88 |
| 其他综合收益 | -2,434,914.92 | -2,434,914.92 | -2,434,914.92 | -2,434,914.92 |
| 专项储备 | 4,893,985.36 | 3,722,523.29 | 3,376,294.96 | 2,575,012.75 |
| 盈余公积 | 153,399,262.34 | 153,399,262.34 | 147,763,425.62 | 147,763,425.62 |
| 未分配利润 | 787,585,097.45 | 773,046,572.4 | 789,994,000.73 | 784,571,937.94 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,683,300,929.98 | 1,667,588,937.34 | 1,678,451,454 | 1,672,228,109 |
| 少数股东权益 | 161,001,521.24 | 161,899,297.12 | 169,553,641.05 | 170,566,275.47 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,844,302,451.22 | 1,829,488,234.46 | 1,848,005,095.05 | 1,842,794,384.47 |
| 负债和股东权益合计 | 3,206,878,734.58 | 2,977,531,229.66 | 3,010,674,509.18 | 3,067,752,254.61 |
| 公告日期 | 2025-04-25 | 2025-04-18 | 2024-10-30 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |